These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31532969)

  • 1. Targeting Huntingtin in Patients with Huntington's Disease.
    Sheikh SI; Guerciolini R
    N Engl J Med; 2019 Sep; 381(12):1181. PubMed ID: 31532969
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting Huntingtin in Patients with Huntington's Disease. Reply.
    Tabrizi SJ; Smith AV; Bennett CF
    N Engl J Med; 2019 Sep; 381(12):1181-1182. PubMed ID: 31532970
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does tissue transglutaminase play a role in Huntington's disease?
    Lesort M; Chun W; Tucholski J; Johnson GV
    Neurochem Int; 2002 Jan; 40(1):37-52. PubMed ID: 11738471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?
    Rangone H; Humbert S; Saudou F
    Pathol Biol (Paris); 2004 Jul; 52(6):338-42. PubMed ID: 15261377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Huntingtin holiday": progress toward an antisense therapy for Huntington's disease.
    Lu XH; Yang XW
    Neuron; 2012 Jun; 74(6):964-6. PubMed ID: 22726826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal huntingtin function: an alternative approach to Huntington's disease.
    Cattaneo E; Zuccato C; Tartari M
    Nat Rev Neurosci; 2005 Dec; 6(12):919-30. PubMed ID: 16288298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Huntington disease].
    Nukina N
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1139-40. PubMed ID: 9577671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntingtin Fibrils Poke Membranes.
    Guedes-Dias P; Holzbaur ELF
    Cell; 2017 Sep; 171(1):32-33. PubMed ID: 28938121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Huntington's disease: flipping a switch on huntingtin.
    Greiner ER; Yang XW
    Nat Chem Biol; 2011 Jun; 7(7):412-4. PubMed ID: 21685885
    [No Abstract]   [Full Text] [Related]  

  • 13. Wild-type huntingtin up-regulates BDNF transcription in Huntington's disease.
    Reilly CE
    J Neurol; 2001 Oct; 248(10):920-2. PubMed ID: 11697536
    [No Abstract]   [Full Text] [Related]  

  • 14. Huntington's disease: degradation of mutant huntingtin by autophagy.
    Sarkar S; Rubinsztein DC
    FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full length huntingtin is not detected in intranuclear inclusions in Huntington's disease brain.
    Thomas P; Wilkinson F; Nguyen TM; Harper PS; Neal JW; Morris GE; Jones AL
    Biochem Soc Trans; 1998 Aug; 26(3):S243. PubMed ID: 9765962
    [No Abstract]   [Full Text] [Related]  

  • 16. Huntingtin and its role in neuronal degeneration.
    Li SH; Li XJ
    Neuroscientist; 2004 Oct; 10(5):467-75. PubMed ID: 15359012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntington's disease: clinical characteristics, pathogenesis and therapies.
    Nakamura K; Aminoff MJ
    Drugs Today (Barc); 2007 Feb; 43(2):97-116. PubMed ID: 17353947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New clues found to Huntington's.
    Barinaga M
    Science; 1995 Nov; 270(5239):1110. PubMed ID: 7502028
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyglutamine expansion and Huntington's disease.
    Bates GP; Mangiarini L; Wanker EE; Davies SW
    Biochem Soc Trans; 1998 Aug; 26(3):471-5. PubMed ID: 9765898
    [No Abstract]   [Full Text] [Related]  

  • 20. Connecting the dots in Huntington's disease with protein interaction networks.
    Giorgini F; Muchowski PJ
    Genome Biol; 2005; 6(3):210. PubMed ID: 15774033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.